Evidence map›Paper›PMID 22795057›Full record

ArticleThe Annals of thoracic surgery2012

Variations in the vascular endothelial growth factor pathway predict pulmonary complications.

Jae Y Kim, Michelle A T Hildebrandt, Xia Pu, Yuanqing Ye, Arlene M Correa, Ara A Vaporciyan, Xifeng Wu, Jack A Roth

Abstract readComparative Study
In one paragraph

Article in The Annals of thoracic surgery, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Study on Intervention Mechanism of Yiqi Huayu Jiedu Decoction on ARDS Based on Network Pharmacology.Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
  7. Article
  8. An endothelial TLR4-VEGFR2 pathway mediates lung protection against oxidant-induced injury.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2016
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jae Y KimCity of Hope National Cancer Center, Division of Thoracic Surgery, Duarte, California 91010, USA. jaekim@coh.org
Michelle A T Hildebrandt
Xia Pu
Yuanqing Ye
Arlene M Correa
Ara A Vaporciyan
Xifeng Wu
Jack A Roth
The University of Texas MD Anderson Cancer Center · USNational Cancer Center · US

Funding

UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI GIBBONS, DON LYNN · 1996 to 2024
$57.4M
Lung Cancer Chemoradiation: Predictors of SurvivalR01CA111646 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WU, XIFENG · 2005 to 2009
$2.9M
NCI NIH HHS CA70907NCI NIH HHS P50 CA070907NCI NIH HHS R01 CA111646NCI NIH HHS R01CA111646
6 · The paper itself

Abstract

backgroundClinical factors predicting pulmonary complications after lung resection have been well described, whereas the role of genetics is unknown. The vascular endothelial growth factor (VEGF) signaling pathway has been linked to acute lung injury. We hypothesized that genetic variations in this pathway may be associated with postoperative pulmonary complications after lung resection.

methodsOne hundred ninety-six single nucleotide polymorphisms (SNPs) in 17 genes in the VEGF pathway were genotyped in a discovery set of 264 patients and a replication set of 264 patients who underwent lobectomy for lung cancer. Multivariable analysis adjusting for baseline clinical factors was used to identify SNPs associated with pulmonary complications. Cumulative and classification and regression tree (CART) analyses were used to further stratify risk groups.

resultsThe overall number of pulmonary complications was 164/528 (31%). The effects of 6 SNPs were consistent in the discovery and replication sets (pooled p value<0.05). The rs9319425 SNP in the VEGF receptor gene FLT1 resulted in a 1.50-fold increased risk (1.15-1.96; p=0.003). A cumulative effect for the number of risk genotypes and complications was also evident (p<0.01). Patients carrying 5 risk genotypes had a 5.76-fold increase in risk (2.73-12.16; p=4.44×10(-6)). Regression tree analysis identified potential gene-gene interactions between FLT1:rs9319425 and RAF1:rs713178. The addition of the 6 SNPs to the clinical model increased the area under the receiver operating characteristic curve by 6.8%.

conclusionsGenetic variations in the VEGF pathway are associated with risk of pulmonary complications after lobectomy. This may offer insight into the underlying biological mechanisms of pulmonary complications.

Indexed as

Polymorphism, Single NucleotidePostoperative ComplicationsAcute Lung InjuryAgedBiomarkersDNAFemaleFollow-Up StudiesGenetic Predisposition to DiseaseGenotypeHumansIncidenceMalePneumonectomyPredictive Value of TestsPrognosisBiomarkersDNAVascular Endothelial Growth Factor A

Identifiers

PMID22795057
PMCPMC3466075
OpenAlexW2000271142

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.